PET PET
  • My Account
  • Subscribe
Become a Friend Donate
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • My Account
  • Subscribe
  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements
PETBioNewsNewsGene-silencing nanocapsules could treat asthma

BioNews

Gene-silencing nanocapsules could treat asthma

Published 13 August 2021 posted in News and appears in BioNews 1108

Author

Semyon Bodian

Volunteer writer
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.

A new treatment that uses nanocapsules to silence a gene responsible for allergic asthmatic reactions has been developed by scientists...

A new treatment that uses nanocapsules to silence a gene responsible for allergic asthmatic reactions has been developed by scientists.

Asthma is a condition that affects a person's breathing capacity in response to an external stimulus. The most common asthma treatment is corticosteroids dispensed through inhalers; however, it is believed that up to ten percent of asthmatics do not respond to this form of therapy. Now, researchers from the University of Connecticut have developed nanocapsules that travel to the body's immune cells, whereupon they degrade in the presence of a transcriptional regulator responsible for the inflammatory response in asthmatics, and release a DNAzyme, which inhibits the allergic immune response.

'There's an unmet need for creating different therapeutics that can suppress asthma for this group of people' said Dr Jessica Rouge, who led the study.

Ninety percent of adult asthmatics have atopic asthma, which means their symptoms are the result of an allergic response. Atopic asthma causes the inflammation and narrowing of their airways as well as the over secretion of mucus from the airway's lining. This is part of an immune response to substances they are allergic to such as house dust mites, and is regulated by the transcription factor GATA3.

The study, published in the journal ACS Nano, found that mice prone to allergic asthmatic attacks from dust mites, registered lower autoimmune responses and inflammation in their lungs and respiratory tract when treated with the nanocapsules containing DNAzymes designed to reduce expression of GATA3, in comparison to a control group. Lower expression of the GATA3 gene in the lung tissue of the mice treated with the nanoparticles was also found.

A similar response was also seen in both the GATA3 gene expression and nanocapsule uptake when human white blood cells were exposed to the nanocapsules.

The group felt that these results further endorsed the suitability of these nanocapsules for use in treating humans with asthma.

'I am happy to be a part of this collaborative research as it marks the beginning of the development of the [nanocapsule] as an effective in vivo nanocarrier' said Shraddha Sawant, a PhD student in Dr Rouge's research group.

Some concerns were expressed by the researchers around the ingestion of nanoparticles triggering inflammatory autoimmune responses. 'Generally speaking, when putting nanoparticles in our lungs, you might think they could cause inflammation. However, we were really excited that at doses we used, the nanocarrier alone didn't cause inflammation' said Dr Rouge.

The nanocapsule design has recently been patented by the research group and they are hoping to secure more funding in order to further characterise their in vivo behaviour as well as how long they last within the body.

Sources and References

  • 11/08/2021
    University of Connecticut Today
    Tiny bubbles: treating asthma with gene silencing nanocapsules
  • 23/06/2021
    ACS Nano
    A GATA3 targeting nucleic acid nanocapsule for in vivo gene regulation in asthma

Related Articles

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
6 May 2022 • 2 minutes read

Single mutation discovered may be genetic cause of lupus

by Sneha Krishnamurthy

A novel mutation in a gene called TLR7 has been identified as directly linked to the development of lupus...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
3 September 2021 • 2 minutes read

RNAi jab to reduce cholesterol available on NHS

by Dr Rachael Boyle

A new anti-cholesterol injection has been accepted for use on the NHS, and may soon be available to patients in an effort to prevent heart attacks and strokes...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
27 June 2017 • 2 minutes read

Gene therapy hope for allergies and asthma

by Dr Rachel Huddart

Life-threatening allergies and asthma could one day be treated by a single injection, say researchers who have successfully treated mice using gene therapy...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
25 July 2016 • 2 minutes read

Switching off rogue gene could prevent asthma

by Dr Nikki Davis

A gene involved in the muscles of the respiratory system may be the trigger for asthma, according to a study...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
22 November 2013 • 2 minutes read

Severe childhood asthma gene identified

by Dr Rachael Panizzo

A gene variant has been discovered and linked to an increased risk of severe childhood asthma. Researchers suggest that a faulty version of the gene CDHR3 may even be the direct cause of the disease in some children...

Leave a Reply Cancel reply

You must be logged in to post a comment.

« CRISPR-based COVID-19 diagnostic detects variants

Data-Label The UK's Leading Supplier Of Medical Labels & Asset Labels

RetiringDentist.co.uk The UK's Leading M&A Company.
easyfundraising
amazon

This month in BioNews

  • Popular
  • Recent
13 June 2022 • 2 minutes read

Drop in diversity of blood stem cells leads to old-age health issues

4 July 2022 • 2 minutes read

Shorter IVF protocol reduces risk of OHSS

4 July 2022 • 2 minutes read

USA scrambles to understand implications of Roe v Wade on fertility industry

4 July 2022 • 2 minutes read

Genetic and epigenetic causes of IVF embryo arrest discovered

4 July 2022 • 2 minutes read

Dutch donor-conceived people seek answers

4 July 2022 • 2 minutes read

Genetic variant increases Alzheimer's risk, especially in women

Subscribe to BioNews and other PET updates for free.

Subscribe
  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856

Subscribe to BioNews and other PET updates for free.

Subscribe
PET PET

PET is an independent charity that improves choices for people affected by infertility and genetic conditions.

  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Navigation

  • About Us
  • Get Involved
  • Donate
  • BioNews
  • Events
  • Engagement
  • Jobs & Opportunities
  • Contact Us

BioNews

  • News
  • Comment
  • Reviews
  • Elsewhere
  • Topics
  • Glossary
  • Newsletters

Other

  • My Account
  • Subscribe

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856